| | | 62640 | | 06.11.2012 | | Sandoz Pharmaceuticals AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Co-Irbesartan Sandoz 150/12,5 mg | Filmtabletten | Coated tablets (Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg) | C09DA04 | CI | | 02 | Co-Irbesartan Sandoz 300/12,5 mg | Filmtabletten | Coated tablets (Irbesartan 300 mg, Hydrochlorothiazide 12.5 mg) | C09DA04 | CI | | 03 | Co-Irbesartan Sandoz 300/25 mg | Filmtabletten | Coated tablets (Irbesartan 300 mg, Hydrochlorothiazide 25 mg) | C09DA04 | CI |
|
|
